July 2023 Price Concessions Final Update


Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (31/07/2023) announced the following final list of price concessions for July 2023:
Drug Pack size Price concession
Aciclovir 200mg tablets 25 £1.76
Atorvastatin 20mg tablets 28 £3.38
Atorvastatin 80mg tablets 28 £3.45
Benzoyl peroxide 5% / Clindamycin 1% gel 30 £11.09
Benzoyl peroxide 5% / Clindamycin 1% gel 60 £21.65
Betahistine 16mg tablets 84 £8.92
Betahistine 8mg tablets 84 £3.73
Brinzolamide 10mg/ml / Timolol 5mg/ml eye drops 5 £8.19
Buprenorphine 8mg sublingual tablets sugar free 7 £4.22
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment 30 £10.67
Celecoxib 100mg capsules 60 5.12
Cinacalcet 30mg tablets 28 £7.77
Cinnarizine 15mg tablets 84 £5.47
Clarithromycin 250mg/5ml oral suspension 70 £4.88
Co-amoxiclav 250mg/125mg tablets 21 £2.69
Co-amoxiclav 250mg/62mg/5ml oral suspension sugar free 100 £2.09
Co-careldopa 12.5mg/50mg tablets 90 £4.56
Codeine 30mg tablets 28 £1.08
Codeine 30mg tablets 100 £3.86
Desmopressin 200microgram tablets 30 21.69
Dorzolamide 20mg/ml eye drops 5 £3.34
Doxycycline 100mg capsules 8 1.02
Enalapril 2.5mg tablets 28 £8.75
Estradiol 10microgram pessaries 24 10.69
Fenofibrate micronised 200mg capsules 28 £3.43
Flucloxacillin 250mg/5ml oral solution 100 £3.40
Flucloxacillin 250mg/5ml oral solution sugar free 100 £3.51
Fludrocortisone 100microgram tablets 30 £6.43
Hydralazine 25mg tablets 56 £4.40
Hydrocortisone 1% cream 15 £0.99
Itraconazole 100mg capsules 15 £4.27
Lansoprazole 15mg orodispersible tablets 28 £2.97
Letrozole 2.5mg tablets 14 £5.89
Mebeverine 50mg/5ml oral suspension sugar free 300 £214.96
Mometasone 0.1% ointment 30 £3.84
Morphine sulfate 10mg/1ml solution for injection ampoules 10 £7.49
Naftidrofuryl 100mg capsules 84 £10.20
Pantoprazole 40mg gastro-resistant tablets 28 £3.53
Paracetamol 500mg effervescent tablets 100 £8.80
Pregabalin 150mg capsules 56 £2.67
Quinine sulfate 200mg tablets 28 £7.87
Rizatriptan 10mg orodispersible tablets sugar free 3 £6.02
Sodium chloride 0.9% nebuliser liquid 2.5ml unit dose ampoules 20 £11.75
Tacrolimus 0.1% ointment 30 £19.23
Tacrolimus 0.1% ointment 60 £40.94
Telmisartan 20mg tablets 28 £3.82
Terbinafine 1% cream 30 £7.27
Terbinafine 1% cream 15 £3.26
Topiramate 100mg tablets 60 £12.35
Topiramate 50mg tablets 60 £16.14
Trazodone 100mg capsules 56 £3.05
Trihexyphenidyl 2mg tablets 84 £3.74
Valsartan 40mg capsules 28 £6.75

Please note: DHSC has agreed to roll over the following price concessions to August 2023:

  • Cinnarizine 15mg tablets (84) £5.47
  • Co-amoxiclav 250mg/125mg tablets (21) £2.69
  • Co-careldopa 12.5mg/50mg tablets (90) £4.56

For the full list of price concessions granted for July 2023, please visit our webpage: cpe.org.uk/priceconcessions

No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.

We encourage pharmacies to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on the Community Pharmacy England website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.

Please  subscribe to our mailing list to receive email updates of any price concessions.

Further information on price  concessions and FAQs about the process  involved  can be found on our website (cpe.org.uk/priceconcessions) To hear more on how the current price  concessions system operates, pharmacy teams can now access a recording of our recent webinar  here.

Improvements to the price concession system

Following significant concerns raised by pharmacies about the unsustainable level of prices imposed by  DHSC  in second half of 2022, it was agreed that an  urgent review of the price concession setting system would take place.

Since this announcement, we have sent a strong and clear message back to Government that pharmacies cannot continue to subsidise the NHS medicines bill. Following the review of the concessionary price process, a package of measures has been developed to improve the system.

One of the solutions agreed between us and DHSC is that from 1st April 2023, all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession.

Furthermore, from May 2023, DHSC has implemented a process to roll over prices to the following month for any concessions requested after the 23rd of the month provided these prices were agreed with us. We are also continuing to work with DHSC on how a ‘retrospective increased payment’ my apply, when appropriate. Further information regarding this concession ‘top-up’ mechanism will be issued once details are finalised.